Tumefactive Multiple Sclerosis: Challenges With Treatment Modalities

被引:1
|
作者
ElSaygh, Jude [1 ]
Kandinova, Nicole [1 ]
Zaher, Anas [1 ]
Sunner, Gurinder K. [1 ]
Kostanyan, Sofya [1 ]
机构
[1] NewYork Presbyterian Brooklyn Methodist Hosp, Internal Med, New York, NY 11215 USA
关键词
high-dose corticosteroids; multiple sclerosis flare-up; intravenous immunoglobulins (ivig); tumefactive sclerosis; diagnosis of multiple sclerosis;
D O I
10.7759/cureus.41845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumefactive multiple sclerosis comprises a rare subset of multiple sclerosis that often poses a diagnostic challenge to physicians. It is unique in its presentation as a solitary lesion, usually larger than 2 cm, with surrounding vasogenic edema, commonly mimicking a primary intracranial malignancy. We present a case of a 25-year-old female with no significant past medical history who presented to our institution with homonymous superior quadrantanopia. During her admission, she underwent a magnetic resonance imaging (MRI) of the brain, which revealed a large lesion in the left temporal area surrounded by marked edema. A thorough workup revealed a diagnosis of tumefactive multiple sclerosis. Subsequently, she was initiated on intravenous immunoglobulin rather than stress dose steroids, given the concern for a superimposed infection. Interestingly, the patient had a paradoxical progression of her symptoms as well as expansion of the vasogenic edema on a repeat MRI. In our case, we highlight the key differences in tumefactive multiple sclerosis diagnosis and management.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Tumefactive multiple sclerosis: an uncommon diagnostic challenge
    Kaeser, Martha A.
    Scalib, Frank
    Lanzisera, Frank P.
    Bub, Glenn A.
    Kettner, Norman W.
    JOURNAL OF CHIROPRACTIC MEDICINE, 2011, 10 (01) : 29 - 35
  • [42] Late-onset tumefactive multiple sclerosis
    Takeuchi, Taizo
    Ogura, Mitsuhiro
    Sato, Morio
    Kawai, Nobuyuki
    Tanihata, Hirohiko
    Takasaka, Isao
    Minamiguchi, Hiroki
    Nakai, Motoki
    Itakura, Toru
    RADIATION MEDICINE, 2008, 26 (09): : 549 - 552
  • [43] Tumefactive Multiple Sclerosis Continues to be a Diagnostic and Therapeutic Challenge
    Rojiani, Amyn
    Krolczyk, Stanley J.
    Murtagh, Reed
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 576 - 577
  • [44] Tumefactive multiple sclerosis: clinical, radiological and cognitive features
    Pita, C.
    Silva, B.
    Alonso, R.
    Eizaguirre, M. B.
    Yastremiz, C.
    Merino, A.
    Vanotti, S.
    Garcea, O.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 541 - 541
  • [46] Pathologically confirmed tumefactive multiple sclerosis presenting as aphasia
    Ahn, Suk-Won
    Kim, Ko-Woon
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 693 - 693
  • [47] Intracerebral hemorrhage during treatment with natalizumab in a patient with multiple sclerosis and tumefactive demyelinating lesions
    Stich, Oliver
    Janowitz, Daniel
    Rauer, Sebastian
    MULTIPLE SCLEROSIS, 2008, 14 : S180 - S180
  • [48] Idiopathic Intracranial Hypertension Preceding Tumefactive Multiple Sclerosis
    Alrashidi, Tala J.
    Nasif, Eman M.
    Alshurem, Mohammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [49] Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders
    Meredith C. Frederick
    Michelle H. Cameron
    Current Neurology and Neuroscience Reports, 2016, 16
  • [50] Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences
    Paul, Friedemann
    Bourdette, Dennis
    NEUROLOGY, 2013, 81 (19) : 1648 - 1649